Platelet Rich Plasma (PRP) Market By Product and Application - Global Industry Analysis And Forecast To 2025

Published On : October 2018 Pages : 180 Category: Medical Devices Report Code : HC101456

Platelet Rich Plasma (PRP) Market By Product (Leukocyte-Rich Fibrin, Pure PRP and Leukocyte-Rich PRP) and Application (General surgery, Ophthalmic Surgery, Orthopedics, Neurosurgery, Cosmetic Surgery & Dermatology and Other Applications) - Global Industry Analysis And Forecast To 2025

Industry Outlook

The Platelet-rich plasma (PRP), otherwise referred to as the autologous conditioned plasma, is a focus of the protein of platelet-rich plasma gained from the whole blood, which is centrifuged to expel cells of red blood. Proof for advantage is poor. As the source of concentrated of the autologous conditioned plasma and blood plasma, the PRP contains a few distinctive development factors and different cytokines. The benefits of the therapy are increased rate in growth of hair, tissue like the tendons, muscles and ligaments can be healed, the inflammation caused by osteoarthritis can be lessen, and some other benefits. Therefore, the Platelet Rich Plasma (PRP) Market is anticipated to expand and has tremendous scope during the forecast period. The global Platelet Rich Plasma (PRP) Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

On the basis of Product the market is further divided into Leukocyte-Rich Fibrin, Pure PRP and Leukocyte-Rich PRP. The Pure PRP section is dominating the market owing to factors like; the product is responsible for elimination of neutrophils & red blood cells which do not have any therapeutic effect but may later cause pain after treatment.

On the basis of Application the market is further divided into General surgery, Ophthalmic Surgery, Orthopedics, Neurosurgery, Cosmetic Surgery & Dermatology and Other Applications. The Orthopedics section is leading the market due to as many issue elated to orthopedics are treated by the help of PRP which lessens the changes of reoccurrence of injury.

Regional Insights

The North American region is leading the global  Platelet Rich Plasma (PRP) Market owing to increase in the numbers of areas of applications, rising number of cases related to orthopedic disorders, etc.

Platelet Rich Plasma (PRP) Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • DR. PRP AMERICA LLC
  • T-Biotechnology (T-LAB)
  • Glofinn Oy
  • Arthrex Inc.
  • Terumo BCT Inc.
  • Stryker
  • EmCyte Corporation
  • Zimmer Biomet
  • DePuy Synthes

Some of the key questions answered by the report are:          

  • What was the market size in 2014 and forecast from 2015 to 2025?
  • What will be the industry market growth from 2015 to 2025?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Platelet Rich Plasma (PRP) Market, By Product, Estimates and Forecast, 2014-2025 ($Million)

o   Leukocyte-Rich Fibrin

o   Pure PRP

o   Leukocyte-Rich PRP

o   Platelet Rich Plasma (PRP) Market, By Application, Estimates and Forecast, 2014-2025 ($Million)

o   General surgery

o   Ophthalmic Surgery

o   Orthopedics

o   Neurosurgery

o   Cosmetic Surgery & Dermatology

o   Other Applications

 

o   Platelet Rich Plasma (PRP) Market, By Region, Estimates and Forecast, 2014-2025 ($Million)

o   North America

§  North America Platelet Rich Plasma (PRP) Market, By Country

o   U.S. Platelet Rich Plasma (PRP) Market

o   Canada Platelet Rich Plasma (PRP) Market

o   Mexico Platelet Rich Plasma (PRP) Market

o   Europe

§  Europe Platelet Rich Plasma (PRP) Market, By Country

o   Germany Platelet Rich Plasma (PRP) Market

o   UK Platelet Rich Plasma (PRP) Market

o   France Platelet Rich Plasma (PRP) Market

o   Russia Platelet Rich Plasma (PRP) Market

o   Italy Platelet Rich Plasma (PRP) Market

o   Rest of Europe Platelet Rich Plasma (PRP) Market

o   Asia-Pacific

§  Asia-Pacific Platelet Rich Plasma (PRP) Market, By Country

o   China Platelet Rich Plasma (PRP) Market

o   Japan Platelet Rich Plasma (PRP) Market

o   South Korea  Platelet Rich Plasma (PRP) Market

o   India Platelet Rich Plasma (PRP) Market

o   Southeast Asia Platelet Rich Plasma (PRP) Market

o   Rest of Asia-Pacific Platelet Rich Plasma (PRP) Market

o   South America

§  South America Platelet Rich Plasma (PRP) Market, By Country

o   Brazil Platelet Rich Plasma (PRP) Market

o   Argentina Platelet Rich Plasma (PRP) Market

o   Columbia Platelet Rich Plasma (PRP) Market

o   Rest of South America Platelet Rich Plasma (PRP) Market

o   Middle East and Africa

§  Middle East and Africa Platelet Rich Plasma (PRP) Market, By Country

o   Saudi Arabia Platelet Rich Plasma (PRP) Market

o   UAE Platelet Rich Plasma (PRP) Market

o   Egypt Platelet Rich Plasma (PRP) Market

o   Nigeria Platelet Rich Plasma (PRP) Market

o   South Africa Platelet Rich Plasma (PRP) Market

o   Rest of MEA Platelet Rich Plasma (PRP) Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2014-2025)

4.1.2.  Canada Market Status and Outlook (2014-2025)

4.1.3.  Mexico Market Status and Outlook (2014-2025)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2014-2025)

4.2.2.  France Market Status and Outlook (2014-2025)

4.2.3.  UK Market Status and Outlook (2014-2025)

4.2.4.  Russia Market Status and Outlook (2014-2025)

4.2.5.  Italy Market Status and Outlook (2014-2025)

4.2.6.  Rest of Europe Market Status and Outlook (2014-2025)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2014-2025)

4.3.2.  Japan Market Status and Outlook (2014-2025)

4.3.3.  Korea Market Status and Outlook (2014-2025)

4.3.4.  India Market Status and Outlook (2014-2025)

4.3.5.  Southeast Asia Market Status and Outlook (2014-2025)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2014-2025)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2014-2025)

4.4.2.  Argentina Market Status and Outlook (2014-2025)

4.4.3.  Columbia Market Status and Outlook (2014-2025)

4.4.4.  Rest of South America Market Status and Outlook (2014-2025)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2014-2025)

4.5.2.  United Arab Emirates Market Status and Outlook (2014-2025)

4.5.3.  Egypt Market Status and Outlook (2014-2025)

4.5.4.  Nigeria Market Status and Outlook (2014-2025)

4.5.5.  South Africa Market Status and Outlook (2014-2025)

4.5.6.  Turkey Market Status and Outlook (2014-2025)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2014-2025)

5.       Platelet Rich Plasma (PRP)  Market, By Product

5.1.     Introduction

5.2.     Global Platelet Rich Plasma (PRP)  Revenue and Market Share by Product (2014-2018)

5.2.1.  Global Platelet Rich Plasma (PRP)  Revenue and Revenue Share by Product (2014-2018)

5.3.     Leukocyte-Rich Fibrin

5.3.1.  Global Leukocyte-Rich Fibrin Revenue and Growth Rate (2014-2018)

5.4.     Pure PRP

5.4.1.  Global Pure PRP Revenue and Growth Rate (2014-2018)

5.5.     Leukocyte-Rich PRP

5.5.1.  Global Leukocyte-Rich PRP Revenue and Growth Rate (2014-2018)

6.       Platelet Rich Plasma (PRP)  Market, By Application

6.1.     Introduction

6.2.     Global Platelet Rich Plasma (PRP)  Revenue and Market Share by Application (2014-2018)

6.2.1.  Global Platelet Rich Plasma (PRP)  Revenue and Revenue Share by Application (2014-2018)

6.3.     General surgery

6.3.1.  Global General surgery Revenue and Growth Rate (2014-2018)

6.4.     Ophthalmic Surgery

6.4.1.  Global Ophthalmic Surgery Revenue and Growth Rate (2014-2018)

6.5.     Orthopedics

6.5.1.  Global Orthopedics Revenue and Growth Rate (2014-2018)

6.6.     Neurosurgery

6.6.1.  Global Neurosurgery Revenue and Growth Rate (2014-2018)

6.7.     Cosmetic Surgery & Dermatology

6.7.1.  Global Cosmetic Surgery & Dermatology Revenue and Growth Rate (2014-2018)

6.8.     Other Applications

6.8.1.  Global Other Applications Revenue and Growth Rate (2014-2018)

7.       Platelet Rich Plasma (PRP)  Market, By Region

7.1.     Introduction

7.2.     Global Platelet Rich Plasma (PRP)  Revenue and Market Share by Regions

7.2.1.  Global Platelet Rich Plasma (PRP)  Revenue by Regions (2014-2018)

7.3.     North America Platelet Rich Plasma (PRP)  by Countries

7.3.1.  North America Platelet Rich Plasma (PRP)  Revenue and Growth Rate (2014-2018)

7.3.2.  North America Platelet Rich Plasma (PRP)  Revenue (Million USD) by Countries (2014-2018)

7.3.3.  United States

7.3.3.1.  United States Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.4.  Canada

7.3.4.1.  Canada Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Mexico

7.3.5.1.  Mexico Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.     Europe Platelet Rich Plasma (PRP)  by Countries

7.4.1.  Europe Platelet Rich Plasma (PRP)  Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Platelet Rich Plasma (PRP)  Revenue (Million USD) by Countries (2014-2018)

7.4.3.  Germany

7.4.3.1.  Germany Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.4.  France

7.4.4.1.  France Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.  UK Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  Russia

7.4.6.1.  Russia Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Italy

7.4.7.1.  Italy Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.     Asia-Pacific Platelet Rich Plasma (PRP)  by Countries

7.5.1.  Asia-Pacific Platelet Rich Plasma (PRP)  Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Platelet Rich Plasma (PRP)  Revenue (Million USD) by Countries (2014-2018)

7.5.3.  China

7.5.3.1.  China Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.4.  Japan

7.5.4.1.  Japan Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Korea

7.5.5.1.  Korea Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.6.  India

7.5.6.1.  India Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.     South America Platelet Rich Plasma (PRP)  by Countries

7.6.1.  South America Platelet Rich Plasma (PRP)  Revenue and Growth Rate (2014-2018)

7.6.2.  South America Platelet Rich Plasma (PRP)  Revenue (Million USD) by Countries (2014-2018)

7.6.3.  Brazil

7.6.3.1.  Brazil Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.4.  Argentina

7.6.4.1.  Argentina Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Columbia

7.6.5.1.  Columbia Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.     Middle East and Africa Platelet Rich Plasma (PRP)  by Countries

7.7.1.  Middle East and Africa Platelet Rich Plasma (PRP)  Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Platelet Rich Plasma (PRP)  Revenue (Million USD) by Countries (2014-2018)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  Egypt

7.7.5.1.  Egypt Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  South Africa

7.7.7.1.  South Africa Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  Turkey

7.7.8.1.  Turkey Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.     DR. PRP AMERICA LLC

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.   Revenue and Market Share

8.2.     T-Biotechnology (T-LAB)

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.   Revenue and Market Share

8.3.     Glofinn Oy

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.   Revenue and Market Share

8.4.     Arthrex Inc.

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.   Revenue and Market Share

8.5.     Terumo BCT Inc.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.   Revenue and Market Share

8.6.     Stryker

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.   Revenue and Market Share

8.7.     EmCyte Corporation

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.   Revenue and Market Share

8.8.     Zimmer Biomet

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.   Revenue and Market Share

8.9.     DePuy Synthes

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.   Revenue and Market Share

9.       Global Platelet Rich Plasma (PRP)  Market Competition, by Manufacturer

9.1.     Global Platelet Rich Plasma (PRP)  Revenue and Market Share by Manufacturer (2016-2017)

9.2.     Global Platelet Rich Plasma (PRP)  Price By Region (2016-2017)

9.3.     Top 5 Platelet Rich Plasma (PRP)  Manufacturer Market Share

9.4.     Market Competition Trend

10.    Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.1. Global Platelet Rich Plasma (PRP)  Revenue (Millions USD) and Growth Rate (2018-2025)

10.2. Platelet Rich Plasma (PRP)  Market Forecast by Regions (2018-2025)

10.2.1.      North America Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.1.1. United States Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.1.2. Canada Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.1.3. Mexico Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.2.      Europe Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.2.1. Germany Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.2.2. France Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.2.3. UK Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.2.4. Russia Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.2.5. Italy Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.2.6. Rest of Europe Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.3.      Asia-Pacific Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.3.1. China Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.3.2. Japan Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.3.3. Korea Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.3.4. India Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.3.5. Southeast Asia Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.3.6. Rest of Asia-Pacific Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.4.      South America Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.4.1. Brazil Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.4.2. Argentina Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.4.3. Columbia Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.4.4. Rest of South America Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.5.      Middle East and Africa Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.5.1. Saudi Arabia Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.5.2. United Arab Emirates Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.5.3. Egypt Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.5.4. Nigeria Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.5.5. South Africa Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.5.6. Turkey Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.2.5.7. Rest of Middle East and Africa Platelet Rich Plasma (PRP)  Market Forecast (2018-2025)

10.3. Platelet Rich Plasma (PRP)  Market Forecast by Product (2018-2025)

10.3.1.      Platelet Rich Plasma (PRP)  Forecast by Product (2018-2025)

10.3.2.      Platelet Rich Plasma (PRP)  Market Share Forecast by Product (2018-2025)

10.4. Platelet Rich Plasma (PRP)  Market Forecast by Application (2018-2025)

10.4.1.      Platelet Rich Plasma (PRP)  Forecast by Application (2018-2025)

10.4.2.      Platelet Rich Plasma (PRP)  Market Share Forecast by Application (2018-2025)


List of Tables

List of Tables and Figures

Figure United States Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Canada Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Mexico Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Germany Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure France Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure UK Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Russia Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Italy Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Europe Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure China Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Japan Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Korea Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure India Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Southeast Asia Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Asia-Pacific Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Brazil Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Argentina Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Columbia Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of South America Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Saudi Arabia Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure United Arab Emirates Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Egypt Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Nigeria Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure South Africa Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Turkey Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Figure Rest of Middle East and Africa Platelet Rich Plasma (PRP) Revenue (Million USD) and Growth Rate (2014-2025)

Table Global Platelet Rich Plasma (PRP) Revenue and Revenue Share by Product (2014-2018)

Figure Global Leukocyte-Rich Fibrin Revenue and Growth Rate (2014-2018)

Figure Global Pure PRP Revenue and Growth Rate (2014-2018)

Figure Global Leukocyte-Rich PRP Revenue and Growth Rate (2014-2018)

Table Global Platelet Rich Plasma (PRP) Revenue and Revenue Share by Application (2014-2018)

Figure Global General surgery Revenue and Growth Rate (2014-2018)

Figure Global Ophthalmic Surgery Revenue and Growth Rate (2014-2018)

Figure Global Orthopedics Revenue and Growth Rate (2014-2018)

Figure Global Neurosurgery Revenue and Growth Rate (2014-2018)

Figure Global Cosmetic Surgery & Dermatology Revenue and Growth Rate (2014-2018)

Figure Global Other Applications Revenue and Growth Rate (2014-2018)

Table Global Platelet Rich Plasma (PRP) Revenue by Regions (2014-2018)

Figure North America Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure North America Platelet Rich Plasma (PRP) Revenue and Growth Rate (2014-2018)

Figure North America Platelet Rich Plasma (PRP) by Countries (2014-2018)

Figure North America Platelet Rich Plasma (PRP) Revenue (Million USD) by Countries (2014-2018)

Figure United States Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure United States Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Canada Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Canada Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Mexico Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Mexico Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Europe Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Europe Platelet Rich Plasma (PRP) Revenue and Growth Rate (2014-2018)

Figure Europe Platelet Rich Plasma (PRP) by Countries (2014-2018)

Figure Europe Platelet Rich Plasma (PRP) Revenue (Million USD) by Countries (2014-2018)

Figure Germany Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Germany Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure France Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure France Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure UK Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure UK Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Russia Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Russia Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Italy Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Italy Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Europe Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Rest of Europe Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Asia-Pacific Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Asia-Pacific Platelet Rich Plasma (PRP) Revenue and Growth Rate (2014-2018)

Figure Asia-Pacific Platelet Rich Plasma (PRP) by Countries (2014-2018)

Figure Asia-Pacific Platelet Rich Plasma (PRP) Revenue (Million USD) by Countries (2014-2018)

Figure China Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure China Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Japan Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Japan Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Korea Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Korea Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure India Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure India Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Southeast Asia Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Southeast Asia Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Rest of Asia-Pacific Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South America Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure South America Platelet Rich Plasma (PRP) Revenue and Growth Rate (2014-2018)

Figure South America Platelet Rich Plasma (PRP) by Countries (2014-2018)

Figure South America Platelet Rich Plasma (PRP) Revenue (Million USD) by Countries (2014-2018)

Figure Brazil Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Brazil Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Argentina Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Argentina Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Columbia Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Columbia Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of South America Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Rest of South America Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Middle East and Africa Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Middle East and Africa Platelet Rich Plasma (PRP) Revenue and Growth Rate (2014-2018)

Figure Middle East and Africa Platelet Rich Plasma (PRP) by Countries (2014-2018)

Figure Middle East and Africa Platelet Rich Plasma (PRP) Revenue (Million USD) by Countries (2014-2018)

Figure Saudi Arabia Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Saudi Arabia Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure United Arab Emirates Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure United Arab Emirates Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Egypt Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Egypt Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Nigeria Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Nigeria Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure South Africa Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure South Africa Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Turkey Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Turkey Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Platelet Rich Plasma (PRP) Growth Rate (2014-2018)

Figure Rest of Middle East and Africa Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2014-2018)

Table DR. PRP AMERICA LLC Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Table T-Biotechnology (T-LAB) Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Glofinn Oy Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Arthrex Inc. Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Terumo BCT Inc. Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Stryker Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Table EmCyte Corporation Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Zimmer Biomet Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Table DePuy Synthes Platelet Rich Plasma (PRP) Price, Revenue, Gross Margin and Market Share (2016-2017)

Figure Global Platelet Rich Plasma (PRP) Market Share by Manufacturer

Figure Global Platelet Rich Plasma (PRP) Revenue and Market Share by Manufacturer

Table Global Platelet Rich Plasma (PRP) Price by Region (2016-2017)

Figure Top 5 Platelet Rich Plasma (PRP) Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Platelet Rich Plasma (PRP) Revenue (Millions USD) and Growth Rate (2018-2025)

Table Platelet Rich Plasma (PRP) Market Forecast by Regions (2018-2025)

Figure North America Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure United States Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Canada Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Mexico Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Europe Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Germany Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure France Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure UK Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Russia Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Italy Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Rest of Europe Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Asia-Pacific Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure China Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Japan Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Korea Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure India Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Southeast Asia Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure South America Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Brazil Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Argentina Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Columbia Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Rest of South America Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Middle East and Africa Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Saudi Arabia Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure United Arab Emirates Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Egypt Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Nigeria Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure South Africa Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Turkey Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Platelet Rich Plasma (PRP) Market Forecast (2018-2025)

Figure Global Platelet Rich Plasma (PRP) Forecast by Product (2018-2025)

Figure Global Platelet Rich Plasma (PRP) Market Share Forecast by Product (2018-2025)

Figure Global Platelet Rich Plasma (PRP) Forecast by Product (2018-2025)

Figure Global Platelet Rich Plasma (PRP) Forecast by Application (2018-2025)

Figure Global Platelet Rich Plasma (PRP) Market Share Forecast by Application (2018-2025)

Figure Global Platelet Rich Plasma (PRP) Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*